| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lauck Andrew is a Director at SRTA. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $785K at current prices.
Lauck Andrew's largest disclosed position is in SRTA as Director, worth about $785K. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | SRTA Strata Critical Medical, Inc. | Director | Buy | 5,000 | $4.37 | $21,825.00 | +3.8% | +9.2% | - |